AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma: Cambridge, UK Monday, January 20, 2025, 09:00 Hrs [IS ...
InnoCare Pharma Limited (OTCMKTS:INCPF – Get Free Report) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 3,295 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback